Immutep

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).

CEO

Marc Voigt

CEOMarc Voigt

Employees

—

Employees—

Headquarters

Sydney, New South Wales (NSW)

HeadquartersSydney, New South Wales (NSW)

Founded

1987

Founded1987

Employees

—

Employees—

IMMP Key Statistics

Market cap

56.66M

Market cap56.66M

Price-Earnings ratio

-1.07

Price-Earnings ratio-1.07

Dividend yield

—

Dividend yield—

Average volume

6.70M

Average volume6.70M

High today

$0.41

High today$0.41

Low today

$0.376

Low today$0.376

Open price

$0.3975

Open price$0.3975

Volume

1.44M

Volume1.44M

52 Week high

$3.53

52 Week high$3.53

52 Week low

$0.376

52 Week low$0.376

IMMP News

TipRanks 2d

Immutep Advances First-in-Class LAG-3 Agonist IMP761 With Positive Phase I Progress

Immutep ( (IMMP) ) has issued an announcement. On March 19, 2026, Immutep reported positive progress from its first-in-human Phase I trial of IMP761, a first-i...

TipRanks 3d

Insignia Financial Ceases to Be Substantial Holder in Immutep After Portfolio Rebalancing

Insignia Financial Ltd ( (AU:IFL) ) has shared an announcement. Insignia Financial Ltd has notified Immutep Limited that, as of 13 March 2026, it has ceased to...

TipRanks 3d

Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761

Immutep Ltd ( (AU:IMM) ) has provided an announcement. Immutep reported positive progress from its first-in-human Phase I trial of IMP761, a first-in-class LAG...

Analyst ratings

71%

of 7 ratings

Buy

28.6%

Hold

71.4%

Sell

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.